We are thrilled to present two posters at the virtual #AACR21 Annual Meeting! The posters include preclinical data from our lead clinical-stage antibody therapies: SRF617 (targeting CD39) and SRF388 (targeting IL-27). Learn more: https://t.co/t2rvOx3Mlb https://t.co/vW1LU3ou8E